PolyPid Ltd
NASDAQ:PYPD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
PolyPid Ltd
PolyPid Ltd
Change in Working Capital
PolyPid Ltd
Change in Working Capital Peer Comparison
TEVA
TARO
MDWD
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Change in Working Capital
-$110k
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Change in Working Capital
-$206m
|
CAGR 3-Years
57%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Change in Working Capital
$28.1m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Change in Working Capital
-₪98.8m
|
CAGR 3-Years
-186%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-55%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Change in Working Capital
-$3.3m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Change in Working Capital
-₪6.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PolyPid Ltd's Change in Working Capital?
Change in Working Capital
-110k
USD
Based on the financial report for Dec 31, 2023, PolyPid Ltd's Change in Working Capital amounts to -110k USD.
What is PolyPid Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
60%
Over the last year, the Change in Working Capital growth was 90%. The average annual Change in Working Capital growth rates for PolyPid Ltd have been 60% over the past three years .
You don't have any saved screeners yet
